NAM Publications, through aidsmap.org, will be an official news partner of the XIX International AIDS Conference (AIDS 2012), according to a post in the aidsmap blog. “Senior editor Keith Alcorn says, ‘This year’s conference will be the biggest yet, and after several years of exciting scientific developments, AIDS 2012 will challenge us all to ask how we can turn the tide of the epidemic using all the new tools and knowledge now at our disposal,'” the blog notes (Hughson, 7/10).
Global Health Conferences and Meetings
“A declaration calling for global support to end the AIDS epidemic was announced [Tuesday] by the International AIDS Society (IAS) and the University of California, San Francisco (UCSF),” an IAS press release (.pdf) reports. “The ‘Washington, D.C. Declaration,’ which seeks to build broad support for beginning to end the AIDS epidemic through a nine-point action plan, will be the official declaration of the XIX International AIDS Conference (AIDS 2012),” which “will take place in Washington, D.C., from 22 to 27 July 2012” (7/10).
“A tremendous amount of attention will be focused on AIDS over the next six weeks — and that’s a great thing,” as the International AIDS Conference (AIDS 2012) convenes in Washington, D.C., from July 22 to 27, U.S. Global AIDS Coordinator Ambassador Eric Goosby writes in an opinion piece in The Hill. “This is a moment of hope,” he adds, continuing, “The world has seen a fundamental transformation in the global AIDS outlook over the past decade, with the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria playing leading roles.”
“The International AIDS Society (IAS) [on Wednesday] announced nine winners of four prestigious scientific awards to be presented during the XIX International AIDS Conference (AIDS 2012) to be held in Washington, D.C., 22â€“27 July,” an IAS press release (.pdf) states. “Presented by the IAS and its partners, these awards recognize scientists conducting high quality HIV research around the world,” the press release notes and provides a link to a chart (.pdf) summarizing the award winners (7/11).
GlobalPost correspondents John Donnelly and Charles Sennott interview USAID Administrator Rajiv Shah “about his perspectives on the AIDS fight,” in this entry in GlobalPost’s “Global Pulse” blog. They discuss U.S. Secretary of State Hillary Clinton’s announcement last week that the administration would put together a “blueprint” for achieving an “AIDS-free generation,” approaches to increasing demand for voluntary medical male circumcision in the developing world, and the closure of the Global Health Initiative office, among other topics, according to the interview transcript (7/27).
In this post in the Human Rights and HIV/AIDS “Now More Than Ever” blog, Michel Kazatchkine, the former executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria and newly-appointed special envoy to U.N. Secretary-General Ban Ki-moon for HIV/AIDS in Eastern Europe and Central Asia, examines why human rights are “so central to the AIDS response.” He writes, “An urgent mobilization is needed to respond to the epidemic in Eastern Europe and Central Asia, including much greater attention to, and involvement of marginalized and criminalized populations, particularly people who use drugs, sex workers, and gay men and other men who have sex with men,” adding, “As Special Envoy, I will continue to speak out loudly and clearly about the need to devote much greater attention to human rights. And I pledge to listen to the voices of those who too often are excluded” (7/26).
GlobalPost’s “Global Pulse” blog examines questions surrounding the use of the antiretroviral Truvada for pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection among people at high risk, as studies released and panel discussions held last week at the XIX International AIDS Conference (AIDS 2012) “raised concerns about the drug’s effect on the future of the AIDS fight.” According to the blog, “Leaders in the fight against AIDS are trying to work through these issues and figure out the best way to make use of Truvada as prevention.” The blog notes that the WHO last week “released a set of guidelines for how to use PrEP in demonstration projects” and quotes AVAC Director Mitchell Warren, AIDS Healthcare Foundation President Michael Weinstein, amfAR Vice President and Director of Public Policy Chris Collins, and Black AIDS Institute President and CEO Phill Wilson (Judem, 7/27).
Highlighting the XIX International AIDS Conference (AIDS 2012), which concluded in Washington, D.C., on Friday, this New York Times editorial examines the future of the global AIDS response. “There is no prospect that scientists will any time soon find the ultimate solutions to the AIDS epidemic, namely a vaccine that would prevent infection with the AIDS virus or a ‘cure’ for people already infected with the virus,” the editorial states, adding, “Even so, health care leaders already have many tools that have been shown in rigorous trials to prevent transmission of the virus, making it feasible to talk of controlling the epidemic within the foreseeable future.” The editorial continues, “Instead of waiting for these future possibilities, [NIAID Director Anthony Fauci] and other health leaders are proposing the broad adoption of other available tools to reduce the spread of the virus so as to produce an ‘AIDS-free generation,’ a goal enunciated last year by Secretary of State Hillary Rodham Clinton.” The editorial adds, “The only question is whether the nations of the world are willing to put up enough money and make the effort to do it” (7/27).
Noting that “[t]he XIX International AIDS Conference [AIDS 2012] has just come to a close amid much talk of the beginning of the end of AIDS, turning the tide on HIV and even a potential cure,” Julio Montaner, former president of the International AIDS Society (IAS) and director of the B.C. Centre for Excellence in HIV/AIDS, writes in a Globe and Mail opinion piece, “It is now more certain than ever that we have the tools, medicines and expertise to stop this epidemic.” He continues, “However, without the political will to expand antiretroviral treatment to everyone in need, the audacious goals set before us in Washington last week will never be met and infection may spiral out of control once again.” He writes, “Politicians have paid little more than lip service to supporting the rollout of antiretroviral treatment in their home countries and around the globe,” and concludes, “Treatment as prevention represents the fundamental building block to achieve our goal. We must find the resolve to deliver on the promise of an ‘AIDS-free generation'” (7/30).
“Charged by Secretary of State Hillary Clinton with developing a blueprint for the next phase of the [U.S. government’s] involvement in the fight against HIV and AIDS, [U.S. Global AIDS Coordinator Ambassador Eric Goosby] … will lead an interagency effort to give clearer meaning to the term, ‘AIDS-free generation,’ and provide a basis for programming,” Sharon Stash, a senior fellow at the Center for Strategic & International Studies’ (CSIS) Global Health Policy Center, writes in the CSIS “Smart Global Health” blog. “Clearly the notion of an ‘AIDS-free generation’ within our reach is a powerful one,” she writes, and asks, “Is the meaning it inspires powerful enough to attract and keep the attention of national policymakers, already burdened with competing priorities in a tight economic environment?” (7/29).